Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04118764 · ClinicalTrials.gov registry record · NA

Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound

A NA study of Alzheimer Disease, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04118764 is a NA study of Alzheimer Disease that has completed, run by Columbia University. The registered enrollment target is 6 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04118764, a NA study of Alzheimer Disease, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test a new technique that may, in the future, help deliver medications to the brain of people with Alzheimer's disease. Participants in this study will undergo a focused ultrasound treatment to the brain, along with Magnetic Resonance Imagine (MRI) and Positron Emission Tomography (PET) scans.

Conditions Studied

Alzheimer Disease

Interventions

  • DRUG Definity
  • DEVICE Neuronavigation-guided single-element focused ultrasound transducer
  • OTHER Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents
  • OTHER Positron Emission Tomography (PET)
  • OTHER Amyvid

Study Locations (1)

New York

  • Columbia University Irving Medical Center/NYPH - New York

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2020-08-06
Est. Completion 2022-09-28
Phase NA

Sponsor

Columbia University

958 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04118764

The ClinicalTrials.gov registry entry for NCT04118764 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 5 interventions - of which Definity is the first listed.

NCT04118764 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04118764 about?

NCT04118764 is a clinical study titled "Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound". The purpose of this study is to test a new technique that may, in the future, help deliver medications to the brain of people with Alzheimer's disease. Participants in this study will undergo a focused ultrasound treatment to the brain, along with Magnetic Resonance Imagine (MRI) and Positron Emissi...

What is the current status of trial NCT04118764?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-08-06. Estimated completion is 2022-09-28.

What conditions does trial NCT04118764 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT04118764?

The interventions under investigation include: Definity (DRUG), Neuronavigation-guided single-element focused ultrasound transducer (DEVICE), Magnetic Resonance Imaging (MRI) with or without gadolinium contrast agents (OTHER), Positron Emission Tomography (PET) (OTHER), Amyvid (OTHER).

Who is sponsoring clinical trial NCT04118764?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04118764 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.